ИММУНОФЕНОТИПИРОВАНИЕ ЛИМФОЦИТОВ ПЕРИФЕРИЧЕСКОЙ КРОВИ У ПАЦИЕНТОВ С COVID-19: КЛИНИКО-ИММУНОЛОГИЧЕСКАЯ ХАРАКТЕРИСТИКА

Авторы

  • Т.У. Арипова Институт иммунологии и геномики человека Академии Наук Республики Узбекистан, Ташкент *..Зангиота-2 Автор
  • А.А. Исмаилова Институт иммунологии и геномики человека Академии Наук Республики Узбекистан, Ташкент *..Зангиота-2 Автор
  • Г.Б. Холбоева Институт иммунологии и геномики человека Академии Наук Республики Узбекистан, Ташкент *..Зангиота-2 Автор
  • С.А. Убайдуллаев Институт иммунологии и геномики человека Академии Наук Республики Узбекистан, Ташкент *..Зангиота-2 Автор
  • Р. Розумбетов Институт иммунологии и геномики человека Академии Наук Республики Узбекистан, Ташкент *..Зангиота-2 Автор
  • У. Акбаров Институт иммунологии и геномики человека Академии Наук Республики Узбекистан, Ташкент *..Зангиота-2 Автор

Ключевые слова:

клеточный иммунитет, иммунофенотипирование лимфоцитов, COVID-19, коронавирусная инфекция, Т-лимфоциты, тяжесть течения.

Аннотация

В данной статье рассмотрено иммунофенотипирование лимфоцитов периферической крови у пациентов с COVID-19: клинико-иммунологическая характеристика.  

Библиографические ссылки

de Groot RJ, Baker SC, Baric RS, et al. Commentary: Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the coronavirus study group. J Virol. 2013; 87(14): 7790- 7792.

Kuiken T, Fouchier RA, Schutten M, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. The Lancet. 2003; 362(9380): 263- 270.

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395(10223): 497- 506.

Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798): 265- 269.

Zhang J, Dong X, Cao Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020; 75: 1730- 1741. Wiley Online.

Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061- 1069.

Fei J, Fu L, Li Y, et al. Reduction of lymphocyte at early stage elevates severity and death risk of COVID-19 patients: a hospital-based case-cohort study [published online ahead of print April 6, 2020]. medRxiv. 2020.

Wang F, Nie J, Wang H, et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. The J Infect Dis. 2020; 221(11): 1762- 1769.

He R, Lu Z, Zhang L, et al. The clinical course and its correlated immune status in COVID-19 pneumonia. J Clin Virol. 2020; 127:104361.

Daniel M. Lasser, Judith Chervenak, Robert M. Moore, Tianying Li, Clementine Knight, Hugo O. Teo, Yogangi Malhotra, Severity of COVID-19 Respiratory Complications during Pregnancy are Associated with Degree of Lymphopenia and Neutrophil to Lymphocyte Ratio on Presentation: A Multicenter Cohort Study, American Journal of Perinatology, 10.1055/s-0041-1732421, (2021).

Diao B, Wang C, Tan Y, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol. 2020; 11(11): 827.

Zheng H-Y, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cellular & Mol Immunol. 2020: 1- 3.

Bermejo-Martin JF, Almansa R, Menéndez R, Mendez R, Kelvin DJ, Torres A. Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection. J Infect. 2020; 80: e23- e24.

Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003; 348(20): 1986- 1994.

Ganji A, Farahani I, Khansarinejad B, Ghazavi A, Mosayebi G. Increased expression of CD8 marker on T-cells in COVID-19 patients. Blood Cells Mol Dis. 2020; 83:102437.

Rokni M, Ghasemi V, Tavakoli Z, Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: comparison with SARS and MERS. Reviews in Medical Virology, 2020.

Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020; 10: 102- 108.

Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020; 71: 762- 768.

He Z, Zhao C, Dong Q, et al. Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. Int J Infect Dis. 2005; 9(6): 323- 330.

Cui W, Fan Y, Wu W, Zhang F, Wang J, Ni A. Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome. Clin Infect Dis. 2003; 37(6): 857- 859.

Chu H, Zhou J, Wong BHY, et al. Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. The J Infect Dis. 2016; 213(6): 904- 914.

Wen An, Ju-seop Kang, Qiuyang Wang, Tae-Eun Kim, Cardiac biomarkers and COVID-19: a systematic review and meta-analysis, Journal of Infection and Public Health, 10.1016/j.jiph.2021.07.016, (2021).

Опубликован

2023-06-06

Как цитировать

ИММУНОФЕНОТИПИРОВАНИЕ ЛИМФОЦИТОВ ПЕРИФЕРИЧЕСКОЙ КРОВИ У ПАЦИЕНТОВ С COVID-19: КЛИНИКО-ИММУНОЛОГИЧЕСКАЯ ХАРАКТЕРИСТИКА. (2023). Центральноазиатский журнал образования и инноваций, 2(6), 151-159. https://in-academy.uz/index.php/CAJEI/article/view/23209